Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2007-10-28 Regulatory Filings
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Suspension from Official Quotation 2 pages ?Kb
Regulatory Filings
2007-10-28 English
Notice of Annual General Meeting/Proxy Form 11 pages ?Kb
AGM Information Classification · 100% confidence The document is titled 'Living Cell Technologies Limited NOTICE OF ANNUAL GENERAL MEETING' and details the agenda for the AGM scheduled on 27 November 2007. It includes resolutions for consideration such as adoption of the Remuneration Report, election and re-election of directors, approval of options under the Employee Share Option Plan, and increase in non-executive directors' fees. The document is a notice to shareholders about the AGM and the items to be voted on, rather than the actual Annual Report or financial statements. It contains no substantive financial data or full reports but rather the meeting agenda and explanatory notes for shareholder voting. Therefore, this document fits the category of AGM Information (AGM-R).
2007-10-25 English
Annual Report to shareholders 69 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'LIVING CELL TECHNOLOGIES ANNUAL REPORT 2006-2007' and contains detailed sections typical of an annual report, including Chairman's Report, CEO Message, Year in Review, Management Team, Corporate Governance Statement, Auditor's Independence Declaration, Consolidated Financial Statements (Income Statement, Balance Sheet, Cash Flow Statement, Notes), Directors' Declaration, and Independent Audit Report. The content covers a full fiscal year (2006-2007) and includes comprehensive financial data and management commentary. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement of the report or a certification document. Therefore, this document fits the definition of an Annual Report (10-K). FY 2007
2007-10-25 English
Notice of General Meeting/Proxy Form 6 pages ?Kb
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING' for Living Cell Technologies Limited, detailing the date, time, and location of the meeting, along with the business to be conducted, specifically the ratification of a share issue pursuant to ASX Listing Rule 7.4. It includes explanatory notes about the share issue, voting exclusions, proxy form instructions, and procedural details for shareholders to appoint proxies and vote. There are no financial statements, management discussion, or detailed financial data present. The document serves as a formal notice and proxy solicitation for a shareholder meeting rather than a report or announcement of financial results or corporate changes. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI).
2007-10-25 English
Trading Halt 2 pages ?Kb
Regulatory Filings
2007-10-24 English
LCT Presents at Rodman and Renshaw Healthcare Conference 2 pages ?Kb
Investor Presentation Classification · 90% confidence The document is a press release announcing that Living Cell Technologies will present at the Rodman & Renshaw 9th Annual Healthcare Conference. It describes the content of the upcoming presentation, including clinical trial data and company background, but does not contain actual financial statements or detailed financial analysis. The document is a presentation announcement rather than the presentation itself or a detailed investor presentation document. It is not an earnings release or annual/interim report. Given the nature of the content and the context, the most appropriate classification is Investor Presentation (IP), as it focuses on company strategy, clinical trial progress, and investor information related to the healthcare conference presentation.
2007-10-22 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.